102 related articles for article (PubMed ID: 3412331)
21. Selective elimination of a B cell subset having acceptor site(s) for T cell-replacing factor (TRF) with biotinylated antibody to the acceptor site(s) and avidin-ricin A-chain conjugate.
Hashimoto N; Takatsu K; Masuho Y; Kishida K; Hara T; Hamaoka T
J Immunol; 1984 Jan; 132(1):129-35. PubMed ID: 6418795
[TBL] [Abstract][Full Text] [Related]
22. Selective killing of target cells by antibody-ricin A chain or antibody-gelonin hybrid molecules: comparison of cytotoxic potency and use in immunoselection procedures.
Colombatti M; Nabholz M; Gros O; Bron C
J Immunol; 1983 Dec; 131(6):3091-5. PubMed ID: 6139402
[TBL] [Abstract][Full Text] [Related]
23. Preparation of antibody (IgG)-ricin A-chain conjugate and its biologic activity.
Miyazaki H; Beppu M; Terao T; Osawa T
Gan; 1980 Dec; 71(6):766-74. PubMed ID: 6974113
[TBL] [Abstract][Full Text] [Related]
24. Use of an antibody-ricin A-chain conjugate to delete neoplastic B cells from human bone marrow.
Muirhead M; Martin PJ; Torok-Storb B; Uhr JW; Vitetta ES
Blood; 1983 Aug; 62(2):327-32. PubMed ID: 6409188
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the selective cytotoxic effects of immunotoxins containing ricin A chain or pokeweed antiviral protein and anti-Thy 1.1 monoclonal antibodies.
Ramakrishnan S; Houston LL
Cancer Res; 1984 Jan; 44(1):201-8. PubMed ID: 6140077
[TBL] [Abstract][Full Text] [Related]
26. Novel synthesis and in vitro characterization of disulfide-linked ricin-monoclonal antibody conjugates devoid of galactose binding activity.
Pietersz GA; Kanellos J; McKenzie IF
Cancer Res; 1988 Aug; 48(16):4469-76. PubMed ID: 3260814
[TBL] [Abstract][Full Text] [Related]
27. Binding and cytotoxic effect of ricin toxin on multivalent hybrid antibody-coated target cells.
Laky M; Mota G; Moraru I; Ghetie V
Immunol Lett; 1987 Jan; 14(2):127-32. PubMed ID: 3495487
[TBL] [Abstract][Full Text] [Related]
28. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.
Ramakrishnan S; Houston LL
Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765
[TBL] [Abstract][Full Text] [Related]
29. Synergy of ricin A chain-containing immunotoxins and ricin B chain-containing immunotoxins in in vitro killing of neoplastic human B cells.
Vitetta ES; Cushley W; Uhr JW
Proc Natl Acad Sci U S A; 1983 Oct; 80(20):6332-5. PubMed ID: 6578512
[TBL] [Abstract][Full Text] [Related]
30. Purification and properties of immunotoxins containing one vs. two deglycosylated ricin A chains.
Ghetie V; Swindell E; Uhr JW; Vitetta ES
J Immunol Methods; 1993 Nov; 166(1):117-22. PubMed ID: 8228282
[TBL] [Abstract][Full Text] [Related]
31. Antibody-ricin conjugates: a method of linkage which blocks the galactose binding site of ricin.
Foxwell BM; Ross WC; Thorpe PE
Behring Inst Mitt; 1984 May; (74):101-7. PubMed ID: 6477350
[TBL] [Abstract][Full Text] [Related]
32. Variants of lymphoid lines produced with ricin A-chain monoclonal antibody conjugates.
Lowe JA; Ling NR; Forrester JA; Cumber AJ; Ross WC
J Immunol Methods; 1985 Jan; 76(1):93-104. PubMed ID: 3918119
[TBL] [Abstract][Full Text] [Related]
33. The effect of antibody valency and lysosomotropic amines on the synergy between ricin A chain- and ricin B chain-containing immunotoxins.
Fulton RJ; Uhr JW; Vitetta ES
J Immunol; 1986 Apr; 136(8):3103-9. PubMed ID: 3958490
[TBL] [Abstract][Full Text] [Related]
34. Preproricin expressed in Nicotiana tabacum cells in vitro is fully processed and biologically active.
Tagge EP; Chandler J; Harris B; Czako M; Marton L; Willingham MC; Burbage C; Afrin L; Frankel AE
Protein Expr Purif; 1996 Aug; 8(1):109-18. PubMed ID: 8812841
[TBL] [Abstract][Full Text] [Related]
35. Properties of immunotoxins against a glycolipid antigen associated with Burkitt's lymphoma.
Wiels J; Junqua S; Dujardin P; Le Pecq JB; Tursz T
Cancer Res; 1984 Jan; 44(1):129-33. PubMed ID: 6690030
[TBL] [Abstract][Full Text] [Related]
36. Specific cytotoxicity of a human immunoglobulin-directed Fab'-ricin A chain conjugate.
Raso V; Griffin T
J Immunol; 1980 Dec; 125(6):2610-6. PubMed ID: 7430640
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy.
Ghetie MA; May RD; Till M; Uhr JW; Ghetie V; Knowles PP; Relf M; Brown A; Wallace PM; Janossy G
Cancer Res; 1988 May; 48(9):2610-7. PubMed ID: 2451562
[TBL] [Abstract][Full Text] [Related]
38. Cytotoxic effect of ricin A-chain conjugates containing monoclonal antibodies against human erythroid cells.
Tonevitsky AG; Agapov II; Ershova GV; Sarma T; Toptygin AYu ; Mechetner EB
Int J Immunopharmacol; 1993 Feb; 15(2):229-35. PubMed ID: 8468120
[TBL] [Abstract][Full Text] [Related]
39. IgE-immunotoxins. II. IgE-ricin A-chain.
Boltansky H; Slater J; Youle R; Isersky C; Kaliner M
Immunopharmacology; 1987 Sep; 14(1):47-62. PubMed ID: 3500150
[TBL] [Abstract][Full Text] [Related]
40. Cytotoxic effect of anti-Mr 67,000 protein immunotoxins on human tumors in a nude mouse model.
Weil-Hillman G; Runge W; Jansen FK; Vallera DA
Cancer Res; 1985 Mar; 45(3):1328-36. PubMed ID: 3971376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
